With more than 20 years of executive experience, Mr. Kapadia advises private equity and commercial for-profit firms in deal strategy, commercial and operational due diligence, merger integration, performance improvement and divestiture management. He has worked with large corporate clients and leading healthcare PE firms and their portfolio companies.
Mr. Kapadia’s notable engagements include supporting a PE portfolio company in the intellectual and developmental disabilities space in due diligence, merger integration and performance improvement for 20+ transactions in a two-year period, which led to 19,800 more individuals served and 11,600 new employees across 40 states and dozens of individual facilities. He also led a global due diligence and integration planning team for a medical device and equipment company’s acquisition of a South Korea-based global gastrointestinal stent business.
Furthermore, Mr. Kapadia served as ODD lead in a PE consortium’s $8.5 billion acquisition of a Clinical Research Organization (CRO); partnered with a PE-owned emergency alert system provider in ODD and integration of a carve-out of a competitive business from a large global healthcare technology business; led ODD and integration planning for a PE portfolio company’s acquisition of a competitor in the animal drug compounding business; and supported a PE-owned government health and human services organization in reduction of overhead costs of $40+ million from usage of shared services, procurement leverage and process automation.
Prior to joining A&M, Mr. Kapadia served as Managing Director with KPMG, where he led the firm’s healthcare and life sciences ODD and merger integration/separation service offerings. Previously, he led corporate strategy and M&A at global healthcare and technology firms, including McKesson and Vocollect (now owned by Honeywell). Earlier, he was a technology strategy consultant with Sapient.
Mr. Kapadia earned a bachelor’s degree in electronics engineering from Walchand Institute of Technology and an MBA from Carnegie Mellon University. He has published thought leadership articles on leading practices for M&A integration and divestitures in healthcare and life sciences.
